Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Psoriasis
Recent news which mentions Psoriasis
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
July 16, 2024
Tickers
ALC
JNJ
RXST
Tags
Crohn's Disease
Psoriasis
Previews
From
Benzinga
New Study Looks At Obscure Cannabinoids For Treating Psoriasis, Eczema And Acne
August 25, 2023
Tickers
ACNE
Tags
Markets
Cannabis
Health Care
From
Benzinga
The Key To Perfect Hair? Myths And Benefits Of CBD For Hair Care
May 28, 2023
Tickers
CBD
HAIR
Tags
General
Benzinga
HAIR
From
Benzinga
Empowering Psoriasis Patients Through Mental Health Support
October 24, 2022
Tickers
BMY
Tags
NYSE:BMY
mental health
Bristol Myers Squibb
From
3BL Media: Corporate Social Responsibility, Energy and Health News
From Misdiagnosis to Building a Support System: Royce Thomas' Experience Living With Psoriasis
April 25, 2022
Tickers
BMY
Tags
Misdiagnosis
Bristol Myers Squibb
Dermatology
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Roivant' Dermavant Showcases New Long-Term Durability, Tolerability Data For Plaque Psoriasis Candidate
March 25, 2022
Tickers
ROIV
Tags
ROIV
Market News
News
From
Benzinga
Can-Fite BioPharma Flags Delay In Piclidenoson Data Readout From Psoriasis Study
March 08, 2022
Tickers
AMGN
CANF
Tags
General
Market News
News
From
Benzinga
Dermata Therapeutics Shares Plunge 20% Premarket: What Investors Need To Know
February 07, 2022
Tickers
DRMA
Tags
General
Market News
DRMA
From
Benzinga
Can Fite's Piclidenoson Destroys Pathological Skin Cells, Lab Study Shows
January 13, 2022
Tickers
CANF
Tags
General
Preclinical Phase
News
From
Benzinga
Arcutis Secures $225M Debt Financing To Fund Potential Launch Of Roflumilast
December 23, 2021
Tickers
ARQT
Tags
News
Financing
Market News
From
Benzinga
Arcutis' Roflumilast Cream For Psoriasis Goes Under FDA Review
December 23, 2021
Tickers
ARQT
Tags
Psoriasis
Briefs
FDA
From
Benzinga
Amgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level
December 21, 2021
Tickers
AMGN
Tags
News
Market News
General
From
Benzinga
Can-Fite Expects Data Readout From Late-Stage Psoriasis Study With Piclidenoson In Q1 2022
December 07, 2021
Tickers
AMGN
CANF
Tags
General
News
Market News
From
Benzinga
vTv Therapeutics Pulls The Plug On Psoriasis Candidate; Cuts Workforce By 65%
December 07, 2021
Tickers
VTVT
Tags
Phase 3 Trial
Penny Stocks
Biotech
From
Benzinga
Amgen's Otezla Meets Primary Goal In Late-Stage Genital Psoriasis Study
December 02, 2021
Tickers
AMGN
Tags
Market News
News
General
From
Benzinga
Bristol Myers' Deucravacitinib Under FDA Review For Plaque Psoriasis
November 29, 2021
Tickers
AMGN
BMY
Tags
BMY
General
Benzinga
From
Benzinga
Zai Lab Posts Encouraging Data From Early-Stage Plaque Psoriasis Trial
October 21, 2021
Tickers
ZLAB
Tags
General
Benzinga
ZLAB
From
Benzinga
Dermata Stock Jumps On Positive Psoriasis Candidate Data
October 19, 2021
Tickers
DRMA
Tags
Benzinga
Health Care
Trading Ideas
From
Benzinga
AnaptysBio Reveals Updated Imsidolimab Data In Severe Form Of Psoriasis
October 04, 2021
Tickers
ANAB
Tags
ANAB
Phase 2 Trial
Health Care
From
Benzinga
Novartis Posts New Data Reinforcing Efficacy, Convenience Of Cosentyx Autoinjector In Psoriasis
September 29, 2021
Tickers
NVS
Tags
Health Care
Biotech
Psoriasis
From
Benzinga
Evelo Biosciences Psoriasis Candidate Shows Benefit In Mid-Stage Study
September 27, 2021
Tickers
EVLO
Tags
Movers
Phase 2 Trial
Health Care
From
Benzinga
vTv Therapeutics Stock Gains As Psoriasis Candidate Shows Favorable Safety Profile
September 24, 2021
Tickers
VTVT
Tags
Biotech
Psoriasis
Penny Stocks
From
Benzinga
Why Are Dermata Therapeutics Shares Trading Higher Today?
September 21, 2021
Tickers
ACNE
DRMA
Tags
Initiation
Psoriasis
Skin Disorder
From
Benzinga
Soligenix To Test Synthetic Hypericin In Psoriasis Patients
September 16, 2021
Tickers
SNGX
Tags
Market News
News
General
From
Benzinga
UCB Gets EU Approval For Bimekizumab In Psoriasis
August 25, 2021
Tickers
NVS
UCBJF
UCBJY
Tags
Psoriasis
Biotech
FDA
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.